Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer

Use of benchtop exactive high resolution and high mass accuracy orbitrap mass spectrometer for screening in horse doping control

(2011) Yves Moulard et al.   ANALYTICA CHIMICA ACTA

Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry

(2011) David M. Schwope et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

On-line SPE LC-MS/MS for the quantification of Δ9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry

(2011) Stefan König et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry

(2011) Andreas Thomas et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

A sensitive assay for the quantification of morphine and its active metabolites in human plasma and dried blood spots using high-performance liquid chromatography–tandem mass spectrometry

(2011) Claudia F. Clavijo et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of ‘designer’ steroids in the equine

(2011) Adam Clarke et al.   Drug Testing and Analysis

Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact

(2011) Nikolay Youhnovski et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Rapid analysis of dried blood spot samples with sub-2-µm LC–MS/MS

(2011) Joanne Mather et al.   Bioanalysis

Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine, and paroxetine analysis

(2010) Julien Déglon et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Plasma and urine profiles of Δ9-tetrahydrocannabinol and its metabolites 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes

(2010) Rudolf Brenneisen et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Dried Blood Spot Analysis: An Easy and Reliable Tool to Monitor the Biochemical Effect of Hematopoietic Stem Cell Transplantation in Hurler Syndrome Patients

(2010) Mieke Aldenhoven et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Recent advances of liquid chromatography–(tandem) mass spectrometry in clinical and forensic toxicology

(2010) Frank T. Peters   CLINICAL BIOCHEMISTRY

HPLC-high resolution mass spectrometry in clinical laboratory?

(2010) Jean-Louis Habib Jiwan et al.   CLINICAL BIOCHEMISTRY

Dexamethasone quantification in dried blood spot samples using LC–MS: The potential for application to neonatal pharmacokinetic studies

(2010) Parul Patel et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Comprehensive plasma-screening for known and unknown substances in doping controls

(2010) Andreas Thomas et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes

(2010) Mario Thevis et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Perspectives of Liquid Chromatography Coupled to Low- and High-Resolution Mass Spectrometry for Screening, Identification, and Quantification of Drugs in Clinical and Forensic Toxicology

(2010) Hans H Maurer   THERAPEUTIC DRUG MONITORING

Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods

(2010) Paul Abu-Rabie et al.   Bioanalysis

Increasing efficiency for dried blood spot analysis: prospects for automation and simplified sample analysis

(2010) Philip Wong et al.   Bioanalysis

Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations

(2010) Neil Spooner et al.   Bioanalysis

The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs

(2010) Philip Denniff et al.   Bioanalysis

Direct Quantitative Bioanalysis of Drugs in Dried Blood Spot Samples Using a Thin-Layer Chromatography Mass Spectrometer Interface

(2009) Paul Abu-Rabie et al.   ANALYTICAL CHEMISTRY

Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules

(2009) Wenkui Li et al.   BIOMEDICAL CHROMATOGRAPHY

The fight against doping: back on track with blood

(2009) Martial Saugy et al.   Drug Testing and Analysis

Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product

(2009) Mario Thevis et al.   Drug Testing and Analysis

Emerging drugs: mechanism of action, mass spectrometry and doping control analysis

(2009) Mario Thevis et al.   JOURNAL OF MASS SPECTROMETRY

On-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of μ-whole blood samples

(2009) Julien Déglon et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Quantitative confirmation of testosterone and epitestosterone in human urine by LC/Q‐ToF mass spectrometry for doping control

(2008) Jonathan P. Danaceau et al.   JOURNAL OF MASS SPECTROMETRY

Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection

(2008) Haiying Zhang et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY